ONCY
Oncolytics Biotech IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$105.20M
P/E Ratio
—
EPS
$-0.30
Beta
0.99
52W High
$1.51
52W Low
$0.33
50-Day MA
$0.98
200-Day MA
$1.05
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
45.45
PEG Ratio
—
About Oncolytics Biotech Inc
Oncolytics Biotech Inc., a developing-stage biopharmaceutical company, focuses on the discovery and development of pharmaceuticals for the treatment of cancer. The company is headquartered in Calgary, Canada.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-28.66M |
| Operating Margin | 0.00% |
| Return on Equity | -769.00% |
| Return on Assets | -171.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.00 |
| Price-to-Book | 1055.04 |
| Price-to-Sales (TTM) | 58.60 |
| EV/Revenue | 51.13 |
| EV/EBITDA | -1.79 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $116.13M |
| Float | $113.67M |
| % Insiders | 2.77% |
| % Institutions | 2.24% |
Analyst Ratings
Consensus ($5.47 target)
2
Strong Buy3
Buy1
HoldData last updated: 4/9/2026